Literature DB >> 12661769

Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.

Seok Choi1, Jun-Ho Lee, Seikwan Oh, Hyewhon Rhim, Sang-Mok Lee, Seung-Yeol Nah.   

Abstract

Treatment with ginsenosides, major active ingredients of Panax ginseng, produces a variety of pharmacological or physiological responses with effects on the central and peripheral nervous systems. Recent reports showed that ginsenoside Rg2 inhibits nicotinic acetylcholine receptor-mediated Na+ influx and channel activity. In the present study, we investigated the effect of ginsenoside Rg2 on human 5-hydroxytryptamine3A (5-HT3A) receptor channel activity, which is also one of the ligand-gated ion channel families. The 5-HT3A receptor was expressed in Xenopus oocytes, and the current was measured using the two-electrode voltage clamp technique. The ginsenoside Rg2 itself had no effect on the oocytes that were injected with H2O as well as on the oocytes that were injected with the 5-HT3A receptor cRNA. In the oocytes that were injected with the 5-HT3A receptor cRNA, the pretreatment of ginsenoside Rg2 inhibited the 5-HT-induced inward peak current (I5-HT) The inhibitory effect of ginsenoside Rg2 on I5-HT was dose dependent and reversible. The half-inhibitory concentrations (IC50) of ginsenoside Rg2 was 22.3 +/- 4.6 microM. The inhibition of I5-HT by ginsenoside Rg2 was non-competitive and voltage-independent. These results indicate that ginsenoside Rg2 might regulate the 5-HT3A receptors that are expressed in Xenopus oocytes. Further, this regulation on the ligand-gated ion channel activity by ginsenosides might be one of the pharmacological actions of Panax ginseng.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12661769

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  8 in total

1.  Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons.

Authors:  Zhi-ying Lin; Li-min Chen; Jing Zhang; Xiao-dong Pan; Yuan-gui Zhu; Qin-yong Ye; Hua-pin Huang; Xiao-chun Chen
Journal:  Acta Pharmacol Sin       Date:  2012-03-12       Impact factor: 6.150

2.  Pharmacology of ginsenosides: a literature review.

Authors:  Kar Wah Leung; Alice Sze-Tsai Wong
Journal:  Chin Med       Date:  2010-06-11       Impact factor: 5.455

3.  Ginseng saponins induce store-operated calcium entry in Xenopus oocytes.

Authors:  Sang Min Jeong; Jun-Ho Lee; Sunoh Kim; Hyewhon Rhim; Byung-Hwan Lee; Jong-Hoon Kim; Jae-Wook Oh; Sang-Mok Lee; Seung-Yeol Nah
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

4.  Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.

Authors:  R M Helliwell; C O ShioukHuey; K Dhuna; J C Molero; J-M Ye; C C Xue; L Stokes
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 5.  Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors.

Authors:  Seung-Yeol Nah
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

6.  GABA-BZD Receptor Modulating Mechanism of Panax quinquefolius against 72-h Sleep Deprivation Induced Anxiety like Behavior: Possible Roles of Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation.

Authors:  Priyanka Chanana; Anil Kumar
Journal:  Front Neurosci       Date:  2016-03-07       Impact factor: 4.677

7.  White Ginseng Ameliorates Depressive Behavior and Increases Hippocampal 5-HT Level in the Stressed Ovariectomized Rats.

Authors:  Daehyuk Jang; Hyun-Ju Lee; Kyungjun Lee; Kyu-Ri Kim; Ran Won; Seung Eun Lee; Insop Shim
Journal:  Biomed Res Int       Date:  2019-02-11       Impact factor: 3.411

Review 8.  Role of Ginseng, Quercetin, and Tea in Enhancing Chemotherapeutic Efficacy of Colorectal Cancer.

Authors:  Linxian Zhao; Hongyu Zhao; Yongqing Zhao; Mingxiu Sui; Jinping Liu; Pingya Li; Ning Liu; Kai Zhang
Journal:  Front Med (Lausanne)       Date:  2022-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.